Menopause Position Statements

Menopause Position Statements

“If you would like to find out what menopause
position statements are applicable to you, it may be
in your best interest to choose to talk to your…”.Meno Martha

Umbrella

What may the Menopause Position Statements Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Clinical Guides
  • Consensus Statements
  • Final Recommendation Statements
  • Global Consensus Statements
  • Guidelines
  • Other Reports
  • Position Papers
  • Position Statements
  • Recommendations
  • Reports
  • Statements
  • White Papers

Date

What can it be important to be clear about with menopause position statements?

It can be important to be clear about the date of all information including the date of menopause position statements because this information may have been updated or retired.

Health Care Provider

What if I would like to find out what menopause position statement information is applicable to me?

If you would like to find out what menopause position statements are applicable to you, it may be in your best interest to choose to talk to your health care provider about this.

Health Topics A-Z

Where may I find Health Topics A-Z related to Menopause Position Statements?

In Health Topics A-Z you may find:

Health Topics A-Z

Links

Where may I find Links related to Menopause Position Statements?

Your Country may have Links similar to:

Links

This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.

BMS   = British Menopause Society
EMAS = European Menopause and Andropause Society
IGCS  = International Gynecologic Cancer Society
IMS    = International Menopause Society

New or Updated

  1. BMS Guidelines
  2. BMS Statement In Response To the Publication of the Updated NICE Menopause Guideline (NG23)
  3. BMS Statement on Testosterone
  4. BMS Tools for Clinicians
  5. BMS Vision: Vision for Menopause Care In the United Kingdom
  6. BMS, IMS, EMAS, RCOG and AMS Joint Statement on Menopausal Hormone Therapy (MHT) and Breast Cancer Risk
  7. Bioidentical HRT [British Menopause Society]
  8. British Gynaecological Cancer Society (BGCS) Ovarian, Tubal and Primary Peritoneal Cancer Guidelines: Recommendations for Practice Update 2024
  9. British Gynaecological Cancer Society and British Menopause Society Guidelines Management of Menopausal Symptoms Following Treatment of Gynaecological Cancer
  10. Calcium In the Prevention of Postmenopausal Osteoporosis: EMAS Guide
  11. Cardiovascular Health After Menopause Transition, Pregnancy Disorders, and Other Gynaecologic Conditions: A Consensus Document From European Cardiologists, Gynaecologists, and Endocrinologists
  12. Cardiovascular Risk Assessment In Women – An Update
  13. Chronic Kidney Disease and Menopausal Health: An EMAS Clinical Guide
  14. Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019–2020
  15. Clinical Practice Guidelines on Postmenopausal Osteoporosis: *An Executive Summary and Recommendations – Update 2019–2020 [Indian Menopause Society]
  16. Compounded Bioidentical Hormones In Endocrinology Practice: An Endocrine Society Scientific Statement
  17. Consumer Video and Podcast Series: 2023 Consumer Videos and Podcasts – NAMS 2023 Nonhormone Therapies Position Statement for Bothersome Menopause Symptoms
  18. Current Management of Pelvic Organ Prolapse In Aging Women: EMAS Clinical Guide
  19. Department of Health Shares the Results of Research About Menopause In Ireland Following the First Government Led Menopause Awareness Campaign In Ireland
  20. Drug Holidays From Bisphosphonates and Denosumab In Postmenopausal Osteoporosis
  21. EMAS Position Statement: Predictors of Premature and Early Natural Menopause
  22. EMAS Position Statement: Thyroid Disease and Menopause
  23. EMAS Position Statement: Vitamin D and Menopausal Health
  24. Eligibility Criteria for the Use Menopausal Hormone Therapy (MHT) In Women With Medical Conditions (II): Endometriosis, Neurological and Autoimmune Diseases
  25. Endometriosis and Menopausal Health: An EMAS Clinical Guide
  26. European Society of Endocrinology Clinical Practice Guideline for Evaluation and Management of Menopause and the Perimenopause
  27. Genitourinary Syndrome of Menopause (GSM) [November 2025]
  28. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025)
  29. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
  30. Global Consensus Recommendations on Menopause In the Workplace: A European Menopause and Andropause Society (EMAS) Position Statement
  31. Global Consensus Statement on Menopausal Hormone Therapy
  32. Guideline on Premature Ovarian Insufficiency
  33. Guidelines and Education: EMAS Position Statements
  34. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations
  35. HRT and the Likelihood of Some Medical Conditions. A Discussion Aid for GPs and Patients. Menopause: Identification and Management (NICE Guideline NG23)
  36. Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions
  37. Info for Professionals: Clinical Practice Guidelines [Indian Menopause Society]
  38. International Menopause Society (IMS) Recommendations and Key Messages on Women’s Midlife Health and Menopause
  39. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder In Women
  40. Joint BMS BSGE BGCS FSRH GIRFT and RCOG Guideline on Management of Unscheduled Bleeding on HRT
  41. Joint BMS, FSRH, RCGP and RCOG Position Statement on the Supply Shortages of Hormone Replacement Therapy (HRT)
  42. Joint Position Statement By the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  43. KKH MCHRI Launches Singapore’s First Set of Menopause Management Guidelines
  44. Making Menopause Work
  45. Management of Menopausal Symptoms Following Treatment of Gynecological Cancer
  46. Management of Menopause for Women With Cardiovascular Disease
  47. Management of Osteoporosis In Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society
  48. Management of Postmenopausal Women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d’Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines
  49. Management of Unscheduled Bleeding on Hormone Replacement Therapy (HRT)
  50. Managing Sleep Disturbance During the Menopause Transition
  51. Measurement of Serum Estradiol In the Menopause Transition
  52. Menopause Knowledge and Education In Women Under 40: Results From An Online Survey
  53. Menopause and Diabetes: EMAS Clinical Guide
  54. Menopause and MHT In 2024: Addressing the Key Controversies – An International Menopause Society White Paper
  55. Menopause and the Workplace: Consensus Recommendations From The Menopause Society
  56. Menopause and the Workplace: Consensus Recommendations From The Menopause Society
  57. Menopause, Wellbeing and Health: A Care Pathway From the European Menopause and Andropause Society
  58. Menopause: Identification and Management [NICE Guideline]
  59. Menopause: Identification and Management [NICE Guideline]
    Menopause Position Statements
  60. NICE Guidelines on Menopause Are Missing Nuance
  61. New FAQ Document – Joint Guideline on Management of Unscheduled Bleeding on HRT
  62. New Menopause Practice Standards
  63. Online Events [International Menopause Society]: CAMS Menopause Hour Webinars – Genitourinary Health [Council of Affiliated Menopause Societies]
  64. Online Events [International Menopause Society]: Past Webinars – 2025: Lifestyle Medicine
  65. Optimising the Menopause Transition: Joint Position Statement By the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  66. Pharmacological Management of Osteoporosis In Postmenopausal Women Guideline Resources
  67. Position Papers and Consensus Statements [International Menopause Society]
  68. Position Statements & Other Reports [North American Menopause Society]
  69. Position Statements [Australasian Menopause Society]
  70. Premature Ovarian Insufficiency [British Menopause Society]
  71. Preventing Obesity in Midlife Women: A Recommendation From the Women’s Preventive Services Initiative
  72. Prevention and Treatment of Osteoporosis In Women [British Menopause Society]
  73. Primary Prevention of Coronary Heart Disease In Women [British Menopause Society]
  74. RCGP, RCOG and BMS Position Statement on the Menopause
  75. Revised Global Consensus Statement on Menopausal Hormone Therapy
  76. Sexual Health and Wellbeing and the Menopause: An EMAS Clinical Guide
  77. Surgical Menopause: A Toolkit for Healthcare Professionals
  78. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society
  79. The 2022 Hormone Therapy Position Statement of The North American Menopause Society
  80. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society
  81. The 2023 Practitioner’s Toolkit for Managing Menopause
  82. The Essential Menopause Curriculum for Healthcare Professionals: A European Menopause and Andropause Society (EMAS) Position Statement
  83. The Mediterranean Diet and Menopausal Health: An EMAS Position Statement
  84. The Menopause Society Statement on Misinformation Surrounding Hormone Therapy
  85. The Updated Practitioner’s Toolkit for Managing Menopause [+ Video]
  86. The Silence and the Stigma: Menopause In Canada
  87. The South African Menopause Society (SAMS) Statement on Compounded (Bioidentical) Menopausal Hormone Therapy
  88. Topical Estrogens and Non-Hormonal Preparations for Postmenopausal Vulvovaginal Atrophy: An EMAS Clinical Guide
  89. Update of the 2015 Evidence Based guideline on Premature Ovarian Insufficiency – Now Published [31 October 2024]
  90. Use of Incretin-Based Therapies In Women Using Hormone Replacement Therapy (HRT)
  91. Webinars: Previous – Changing the Paradigm for Earlier Osteoporosis Prevention
  92. World Menopause Day 2024: The IMS White Paper: Menopause and MHT In 2024: Addressing the Key Controversies [Multiply Languages]
  93. World Menopause Day 2025 [18 October]
    Menopause Position Statements
  94. World Menopause Day 2025: The IMS White Paper: The Role of Lifestyle Medicine In Menopausal Health: A Review of Non-Pharmacologic Interventions [Multiply Languages]

Topic Last Updated: 21 February 2026 – Topic Last Reviewed: 21 February 2026
Print Friendly, PDF & Email
/by
Copyright © 2011 – 2026 Meno Martha®. All Rights Reserved. | The information provided on  Meno Martha, Meno Martha International Menopause Directory and/or menomartha.com is for informational or educational purposes only. It is not intended to substitute for or replace the medical advice, diagnosis or treatment of your qualified health care providers. | By using this service you accept Meno Martha International Menopause Directory’s Terms of Use which incorporate Meno Martha International Menopause Directory’s Links Policy. | Meno Martha® is a registered Trademark | Meno Martha International Menopause Directory® is a registered Trademark.
Meno Martha and/or Meno Martha International Menopause Directory do not sell, produce or endorse any products, services or content of any kind including pills or potions for ‘menopause symptom relief’. Please Contact Us if you see or receive any advertisements allegedly by, for or on behalf of Meno Martha and/or Meno Martha International Menopause Directory.